Yes, Cosentyx is classified as a specialty drug. Nearly every insurance plan in the United States places it on a specialty medication tier, which means higher out-of-pocket costs, mandatory prior authorization, and dispensing through specialty pharmacies rather than your local drugstore. The average annual cost per patient in the commercial market was roughly $39,882 in 2023, well above the thresholds insurers use to define specialty medications.
Why Cosentyx Qualifies as a Specialty Drug
Insurance companies and pharmacy benefit managers generally classify a drug as “specialty” when it meets several criteria: high cost, complex manufacturing, special storage or handling, required monitoring, or limited distribution. Cosentyx checks most of these boxes.
First, the price. The list price as of mid-2025 is $7,936.48 per month for a self-injectable dose package, regardless of whether you’re on the 150 mg or 300 mg strength. Most insurers set their specialty threshold somewhere between $600 and $1,000 per month, so Cosentyx exceeds that by a wide margin. Second, it’s a biologic, meaning it’s made from living cells rather than simple chemical synthesis. Biologics are inherently more complex and expensive to produce than traditional pills. Third, Cosentyx must be refrigerated between 36°F and 46°F, kept in its original carton to protect it from light, and never frozen. It can only sit at room temperature for up to four days before it degrades. That cold-chain requirement rules out standard pharmacy shelves and normal mail delivery.
How It Works in Your Body
Cosentyx is a lab-made antibody that targets a specific inflammatory protein called IL-17A. In conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis, the immune system overproduces IL-17A, which triggers a cascade of inflammation. The drug binds to that protein and blocks it from activating its receptor, essentially turning down the volume on one of the immune system’s loudest inflammatory signals. This is why it works across several different autoimmune conditions that share that same underlying driver.
Conditions It Treats
The FDA has approved Cosentyx for six conditions:
- Moderate to severe plaque psoriasis in patients 6 and older
- Psoriatic arthritis in patients 2 and older
- Ankylosing spondylitis in adults
- Non-radiographic axial spondyloarthritis in adults with objective signs of inflammation
- Enthesitis-related arthritis in children 4 and older
- Moderate to severe hidradenitis suppurativa in adults
The breadth of approved uses is one reason Cosentyx remains one of the higher-volume specialty drugs on the market.
What Specialty Tier Means for Your Costs
When a drug sits on a specialty tier, you typically pay a percentage of the cost (coinsurance) rather than a flat copay. On a standard preferred-brand tier, you might pay $40 or $50 per fill. On a specialty tier, coinsurance of 25% to 40% can translate into thousands of dollars per month before any assistance kicks in.
Novartis, the manufacturer, offers a copay program for patients with private insurance that can reduce your cost to $0 per month. In 2024, 84% of eligible patients using this program paid nothing out of pocket. However, the copay card is not available if you have Medicare, Medicaid, TRICARE, or other federal or state coverage.
For patients whose insurance denies coverage after a prior authorization request, a separate program called “Covered Until You’re Covered” provides Cosentyx at no cost for up to two years while you appeal the denial. You must file that appeal within the first 90 days of enrollment. Uninsured patients or those on government insurance may qualify for free medication through the Novartis Patient Assistance Foundation, a nonprofit with income-based eligibility. If you choose to pay out of pocket entirely, the direct-to-patient price is $3,674.44 per month at the 300 mg dose or $1,837.22 per month at 150 mg, a roughly 55% discount off the list price.
Prior Authorization Is Almost Universal
In 2023, approximately 100% of reporting insurance plans required prior authorization before covering Cosentyx. That means your doctor needs to submit documentation proving you have a qualifying diagnosis and, in most cases, that you’ve already tried and failed less expensive treatments first.
For skin conditions, insurers typically want to see that topical therapies weren’t enough. For joint conditions, they often require a trial of anti-inflammatory medications or older disease-modifying drugs like methotrexate. The prescribing doctor usually needs to be a relevant specialist, such as a dermatologist for psoriasis or a rheumatologist for arthritis. Once approved, reauthorization requires proof that the drug is actually working for you and that you aren’t combining it with another biologic.
Where You Can Fill the Prescription
Because of its refrigeration needs and high cost, Cosentyx is dispensed through specialty pharmacies rather than retail chains. Your insurer may require you to use a specific specialty pharmacy from their network. The injectable version you use at home comes as a prefilled pen or syringe that ships in temperature-controlled packaging directly to your door. An intravenous formulation also exists, but it must be prepared and administered by a healthcare professional in a clinical setting.
If you’re unsure which specialty pharmacy your plan works with, the manufacturer’s patient support line can run a benefits verification to identify your options and walk you through the approval process.